|
The pharmaceutical industry is ready to respond to patients’ rising needs and emerging global health challenges – it needs a conducive legislative and policy framework, and robust research ecosystem that supports innovation.
Recent crises have highlighted the critical need for Europe to secure and strengthen its position as leader in medical innovation. As the European Commission works on the next Pharmaceutical Strategy, we need to ensure Europe has the right environment to bring the next generation of treatments to patients. The challenge for the coming decades is not if medical innovation will happen but where it will happen.
|
